Mount Sinai study points to efficacy of convalescent COVID-19 plasma treatment


A team of researchers at Mount Sinai and the Johns Hopkins Bloomberg School of Public Health found that 39 COVID-19 patients who were treated with convalescent COVID-19 plasma had better outcomes than patients who were not treated with convalescent plasma. Notably, patients improved both in terms of lower oxygenation requirements and in overall mortality. Read more here and here.

© 2020 by Covid Plasma Initiative Foundation

The Yitzchok Lebovits COVID Plasma Initiative is dedicated in memory of R’ Yitzchok a"h Ben R’ Moshe Eliezer y"blt, who recently passed away. R' Yitzchok was a brother of Chaim Lebovits who has been a driving force behind every aspect of this initiative to bring this life-saving therapy to the people who need it.